Page last updated: 2024-12-05

propylene glycol methyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Propylene glycol methyl ether (PGME) is a colorless, flammable liquid with a mild, ethereal odor. It is a solvent commonly used in various industries, including paints, coatings, inks, adhesives, and pharmaceuticals. PGME is synthesized by reacting propylene oxide with methanol in the presence of a catalyst. It acts as a solvent, plasticizer, and viscosity modifier. PGME is studied for its potential applications in diverse fields due to its excellent solvency properties, low toxicity, and biodegradability. It is considered a relatively safe solvent with low acute toxicity. However, prolonged or repeated exposure may cause skin and eye irritation, respiratory problems, and potential health hazards. Research into PGME focuses on its environmental impact, alternative synthesis methods, and its use as a green solvent in sustainable applications.'

propylene glycol methyl ether: RN given refers to unspecified methoxypropanol; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7900
CHEMBL ID3186306
MeSH IDM0046597

Synonyms (85)

Synonym
dowtherm 209
nsc-2409
.alpha.-propylene glycol monomethyl ether
nsc2409
2-propanol, 1-methoxy-
107-98-2
propylene glycol methyl ether
dowanol-33b
1-methoxy-2-hydroxypropane
wln: qy1 & 1o1
2-methoxy-1-methylethanol
1-methoxy-2-propanol
1-methoxypropan-2-ol
inchi=1/c4h10o2/c1-4(5)3-6-2/h4-5h,3h2,1-2h
einecs 203-539-1
hsdb 1016
nsc 2409
brn 1731270
ai3-15573
un3092
dowanol 33b
propasol solvent m
closol
ucar solvent lm (obs.)
methyl proxitol
methoxyisopropanol
propylene glycol monomethyl ether
pgme
1-methoxy-2-propanol, >=99.5%
FT-0654880
FT-0655258
propylene glycol 1-monomethyl ether
M0126
NCGC00249123-01
AKOS009158246
propyleneglycol monomethylether
unii-74z7jo8v3u
1-methoxy-2-propanol [un3092] [flammable liquid]
3-01-00-02146 (beilstein handbook reference)
ec 203-539-1
propylene glycol 1-methyl ether
74z7jo8v3u ,
dtxsid8024284 ,
dtxcid804284
cas-107-98-2
NCGC00256978-01
tox21_303269
tox21_201803
NCGC00259352-01
FT-0647598
FT-0608005
methoxyisopropanol [inci]
(+/-)-1-methoxy-2-propanol
1-methoxy-2-hydroxypropane [hsdb]
methoxy isopropanol
rac-1-methoxy-2-propanol
2-methoxy-1-methyl ethanol
propylene glycol monomethylether
3-methoxy-propan-2-ol
methoxy-2-propanol
1-methoxy-propan-2-ol
(+/-)2-methoxy-1-methylethanol
propylene glycol mono methyl ether
propan-1-methoxy-2-ol
glycol ether pm
propan-2-ol, 1-methoxy-
icinol pm
solvent pm
methoxypropanol, .alpha. isomer
ucar solvent lm
1,2-propylene glycol 1-monomethyl ether
CHEMBL3186306
mfcd01632587
mfcd00004537
2-propanol, methoxy-
1-methoxy-2-propanol, analytical standard
1-methoxy-2-propanol, 98%
E72455
Q1884806
propyleneglycol monomethyl ether
SB44662
SB44649
EN300-73396
SY012761
Z825742124

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Overexposure to EGME has resulted in adverse effects on testes, bone marrow and lymphoid tissues in laboratory animals."( Ethylene glycol monomethyl ether and propylene glycol monomethyl ether: metabolism, disposition, and subchronic inhalation toxicity studies.
Calhoun, LL; Hermann, EA; Landry, TD; Miller, RR; Young, JT, 1984
)
0.27
" Based upon this analysis, concentrations of PGEs are unlikely to pose adverse risks to the environment."( An examination of the physical properties, fate, ecotoxicity and potential environmental risks for a series of propylene glycol ethers.
Davis, JW; Staples, CA, 2002
)
0.31
" Also, the severity of effects caused by MPA was less than that of MAA, and unlike MAA, MPA was not selectively toxic to the fetus."( Significance of 2-methoxypropionic acid formed from beta-propylene glycol monomethyl ether: integration of pharmacokinetic and developmental toxicity assessments in rabbits.
Breslin, WJ; Carney, EW; Dryzga, MD; Hansen, SC; Johnson, KA; Liberacki, AB; Pottenger, LH; Tornesi, B, 2003
)
0.32
" The no observed adverse effect level (NOAEL) for 13-week inhalation exposures to Methoxyisopropanol was 1000 ppm in rats and rabbits."( Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics.
, 2008
)
0.35

Pharmacokinetics

ExcerptReferenceRelevance
" Accordingly, a series of in vivo developmental toxicity, whole embryo culture, and in vivo pharmacokinetic experiments were conducted in New Zealand White rabbits (highly sensitive to these compounds) to better understand the developmental toxicity potential of MPA and the kinetics of its formation from beta-PGME."( Significance of 2-methoxypropionic acid formed from beta-propylene glycol monomethyl ether: integration of pharmacokinetic and developmental toxicity assessments in rabbits.
Breslin, WJ; Carney, EW; Dryzga, MD; Hansen, SC; Johnson, KA; Liberacki, AB; Pottenger, LH; Tornesi, B, 2003
)
0.32
" Data from a variety of pharmacokinetic and mechanistic studies have been incorporated into a PBPK model for PM and its acetate in rats and mice."( Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans.
Corley, RA; Gies, RA; Weitz, KK; Wu, H, 2005
)
0.33
" The dose-response relationship for sedation was characterized using internal dose measures as predicted by a physiologically-based pharmacokinetic (PBPK) model for PGME and its acetate."( Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether
Corley, R; Gargas, ML; Kirman, CR; Sweeney, LM, 2005
)
0.52

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationship for sedation was characterized using internal dose measures as predicted by a physiologically-based pharmacokinetic (PBPK) model for PGME and its acetate."( Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether
Corley, R; Gargas, ML; Kirman, CR; Sweeney, LM, 2005
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Household Essentials1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Method Squirt and Mop Wood Floor Cleaner Refill Almond -- 68 fl ozMethodHousehold EssentialsDMDM hydantoin, methoxyisopropanol2024-11-29 10:47:42

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency18.95670.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency48.01670.000817.505159.3239AID1159527; AID1159531
farnesoid X nuclear receptorHomo sapiens (human)Potency21.87510.375827.485161.6524AID743220
estrogen nuclear receptor alphaHomo sapiens (human)Potency50.01770.000229.305416,493.5996AID743075; AID743079
aryl hydrocarbon receptorHomo sapiens (human)Potency70.19700.000723.06741,258.9301AID743085
activating transcription factor 6Homo sapiens (human)Potency61.65240.143427.612159.8106AID1159516
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency78.76240.000323.4451159.6830AID743066
heat shock protein beta-1Homo sapiens (human)Potency56.22740.042027.378961.6448AID743210
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (16.92)18.7374
1990's7 (10.77)18.2507
2000's20 (30.77)29.6817
2010's12 (18.46)24.3611
2020's15 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.53 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index94.97 (26.88)
Search Engine Supply Index2.65 (0.95)

This Compound (47.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.82%)5.53%
Reviews3 (4.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other66 (92.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]